Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FSGDD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,783
Award facts
- Contract value 100% obligated
- $38,782.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $38,782.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Stelara 45 mg/0.5 ml syringes. The contract is non-set-aside and competitively awarded, with an ultimate completion date of September 29, 2025. AmerisourceBergen will perform work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999 and extending through December 2026, which enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's extensive federal contract portfolio demonstrates its capability to deliver diverse pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies to customers such as the Defense Health Agency and U.S. Coast Guard. The current delivery order for Stelara, an immunosuppressive medication, reflects the company's ongoing role as a key vendor for DoD pharmaceutical supply needs.
Quick answers
Who was awarded contract SPE2DB25FSGDD?
SPE2DB25FSGDD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FSGDD worth?
The government has obligated $38,783 on SPE2DB25FSGDD.
Is contract SPE2DB25FSGDD an order under another contract?
Yes. SPE2DB25FSGDD is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FSGDD competed?
The extent of competition for SPE2DB25FSGDD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award